AstraZeneca will pay $425 million to settle lawsuits on behalf of consumers who suffered kidney injuries while using its heartburn medications Nexium and Prilosec. AstraZeneca in a statement said ...

Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a ...

A former AstraZeneca Pharmaceuticals LP sales worker adequately alleged she was fired after the company rejected her request ...

The lawsuit surrounded AstraZeneca’s blockbuster lung cancer ... with three of its own patent infringement suits. The latest settlement was in 2022, blocking Alembic Pharmaceuticals from making ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over ... GSK said in June that it had settled a lawsuit relating to Zantac – known chemically as ranitidine – and that ...

AstraZeneca was sued on Aug. 26 in Pennsylvania Eastern District Court over alleged employment discrimination. The court case was brought by the Gold Law Firm on behalf of a former senior user ...

AstraZeneca unit and Samsung Bioepis resolve their patent dispute over a biosimilar | Settlement follows FDA approval for the ...

The lawsuits against AstraZeneca Families of individuals affected by adverse vaccine reactions continue to pursue legal recourse against AstraZeneca and the Serum Institute of India. Venugopalan ...

After a landmark $US425 million settlement in the United States, the drugs are being investigated in Australia over alleged ...

Detailed results from one of AstraZeneca's key lung cancer trials released on Monday showed that its experimental precision drug did not significantly improve overall survival results for patients in ...

India's confirmed mpox case from an older virus strain, MBX Biosciences' US IPO plans, AstraZeneca's trial results of a lung ...